EP3774879
C-enda mótefnistilbrigði
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.3.2019EP published:
28.1.2026EP application number:
19722273.0
EP translation filed:
27.3.2026Grant published:
8.4.2026EPO information:
European Patent Register
Max expiry date:
28.3.2039Expiry date:
28.3.2027Next due date:
31.3.2027
Title in English:
C-TERMINAL ANTIBODY VARIANTSLanguage of the patent:
English
Timeline
Today
29.3.2019EP application
28.1.2026EP Publication
27.3.2026Translation submitted
8.4.2026Registration published
28.3.2027Expires
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US
Inventor
Name:
HUANG, ZheAddress:
Thousand Oaks, CA 91320-1799, US
Name:
STEVENS, Jennitte, LeAnnAddress:
Thousand Oaks, CA 91320-1799, US
Name:
FLYNN, GregoryAddress:
Thousand Oaks, CA 91320-1799, US
Name:
FODOR, SzilanAddress:
Thousand Oaks, CA 91320-1799, US
Name:
DARIS, MarkAddress:
Thousand Oaks, CA 91320-1799, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862650762 PDate:
30.3.2018Country:
US
Number:
201962812741 PDate:
1.3.2019Country:
US
Classification
Categories:
C07K 16/00, C07K 16/22, A61P 19/10
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 12.3.2026
Expires: 28.3.2027
Payer: Árnason Faktor ehf.